Bionano Genomics, Inc.
$1.31
▲
0.84%
2026-04-21 05:44:01
bionano.com
NCM: BNGO
Explore Bionano Genomics, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$14.53 M
Current Price
$1.31
52W High / Low
$5.5 / $1.06
Stock P/E
—
Book Value
$4.14
Dividend Yield
—
ROCE
-65.83%
ROE
-66.15%
Face Value
—
EPS
$-4.85
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
95
Beta
1.6
Debt / Equity
38.03
Current Ratio
1.98
Quick Ratio
1.74
Forward P/E
-1.02
Price / Sales
0.44
Enterprise Value
$10.16 M
EV / EBITDA
-0.43
EV / Revenue
0.36
Rating
Strong Buy
Target Price
$5.5
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Cuprina Holdings (Cayman) Limited | $0.33 | — | $2.47 M | — | 34.48% | -1.39% | $9.5 / $0.28 | $0.28 |
| 2. | ICU Medical, Inc. | $130.58 | 4,461.76 | $3.27 B | — | 3.08% | 0.04% | $160.29 / $107 | $86.03 |
| 3. | Milestone Scientific Inc. | $0.29 | — | $23.33 M | — | -155% | -1.32% | $1.11 / $0.22 | $0.04 |
| 4. | Anbio Biotechnology | $26.98 | 380.56 | $3.88 B | — | 11.61% | 27.05% | $55.65 / $6.05 | $0.63 |
| 5. | DENTSPLY SIRONA Inc. | $12.79 | — | $2.61 B | 5.5% | 6.17% | -36.43% | $17.18 / $9.85 | $6.71 |
| 6. | AngioDynamics, Inc. | $10.79 | — | $449.55 M | — | -11.8% | -17.47% | $13.99 / $8.36 | $4.16 |
| 7. | Becton, Dickinson and Company | $155.63 | 25.5 | $44.7 B | 2.65% | 6.35% | 6.96% | $187.35 / $127.54 | $88.79 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 7.95 M | 7.37 M | 6.73 M | 6.46 M | 8.16 M | — |
| Operating Profit | -8.54 M | -8.54 M | -7.8 M | -8.46 M | -11.8 M | — |
| Net Profit | -7.93 M | -8.5 M | -6.86 M | -3.1 M | -20.12 M | — |
| EPS in Rs | -0.72 | -0.77 | -0.62 | -0.28 | -1.81 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 28.51 M | 30.78 M | 36.12 M | 27.8 M |
| Operating Profit | -33.34 M | -76.28 M | -137.22 M | -131.7 M |
| Net Profit | -26.39 M | -112.02 M | -232.49 M | -132.6 M |
| EPS in Rs | -2.38 | -10.1 | -20.96 | -11.95 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 73.58 M | 76.67 M | 214.4 M | 307.5 M |
| Total Liabilities | 29.16 M | 41.3 M | 118.25 M | 58.1 M |
| Equity | 44.42 M | 35.38 M | 96.16 M | 249.4 M |
| Current Assets | 45.39 M | 39.49 M | 140.12 M | 157.3 M |
| Current Liabilities | 22.94 M | 37.34 M | 100.03 M | 35.88 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -16.34 M | -68.92 M | -125.18 M | -124.82 M |
| Investing CF | -12.75 M | 73.84 M | 24.16 M | 82.77 M |
| Financing CF | 24.04 M | -13.69 M | 113.81 M | 23.01 M |
| Free CF | -16.34 M | -69.03 M | -126.87 M | -128.12 M |
| Capex | — | -0.1 M | -1.69 M | -3.3 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -14.79% | 29.9% | — | — |
| Earnings Growth % | 51.82% | -75.34% | — | — |
| Profit Margin % | -363.98% | -643.74% | -476.93% | — |
| Operating Margin % | -247.85% | -379.95% | -473.7% | — |
| Gross Margin % | 1.23% | 26.49% | 21.38% | — |
| EBITDA Margin % | -309.93% | -613.35% | -433.69% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-01-27 | 1:0.0166667 |
| 2023-08-07 | 1:0.1 |